Clark Paramore MSPH

L. Clark Paramore, MSPH, is the Head of Value Demonstration at bluebird bio in Cambridge, MA. Mr. Paramore is responsible for creating and leading the value demonstration strategy for bluebird bio’s portfolio of gene therapies, including health economics and outcomes research evidence generation. Mr. Paramore is actively engaged in assessing the relevance and application of existing value frameworks for one-time transformative therapies, such as those being developed by bluebird bio. Prior to joining bluebird bio Mr. Paramore was Vice President and Senior Research Scientist at Evidera, Inc. in Lexington, MA. In this capacity, Mr. Paramore oversaw a range of scientific

projects including economic models, systematic literature reviews, dossier development, and strategic consulting for biopharmaceutical clients in the area of value development/evidence generation for new products. His experience in pharmacoeconomics spans over 20 years with multiple publications in peer-reviewed journals. Mr. Paramore received his Master’s degree in health policy from the School of Public Health at the University of North Carolina at Chapel Hill and his undergraduate degree in public policy from Duke University. Mr. Paramore has extensive experience with nationally representative data sets, including the NMES, MEPS, NHIS, HCUP, NAMCS, CPS, and the MCBS. His articles have appeared in International Journal of Technology Assessment in Health Care, American Journal of Managed Care, American Journal of Public Health, Journal of Pain and Symptom Management, and Value in Health.